BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 207136)

  • 41. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histologic effects of Amipaque (metrizamide) and various contrast media on mouse peritoneum.
    Berner A; Johansen JG
    Invest Radiol; 1978; 13(2):161-2. PubMed ID: 659088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EEG disturbances following myelography, cisternography and ventriculography with metrizamide.
    Lundervold A; Sortland O
    Acta Radiol Suppl; 1977; 355():379-89. PubMed ID: 318150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complications of water-soluble contrast lumbar myelography. Review of the literature and case report.
    Bonneau R; Morris JM
    Spine (Phila Pa 1976); 1978 Dec; 3(4):343-5. PubMed ID: 741241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Some unusual complications of myelography and lumbosacral radiculography.
    Bohutová J; Vojír R; Kolár J; Grepl J
    Diagn Imaging; 1979; 48(6):320-5. PubMed ID: 230946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiography with metrizamide. Animal experiments and preliminary clinical experiences.
    Almén T
    Acta Radiol Suppl; 1977; 355():419-30. PubMed ID: 400907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of a new water-soluble iodinated myelographic contrast medium with markedly reduced convulsive effects.
    Hilal SK; Dauth GW; Hess KH; Gilman S
    Radiology; 1978 Feb; 126(2):417-22. PubMed ID: 414304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thoracic and cervical myelography with metrizamide. Clinical experiences with a water-soluble, non-ionic contrast medium.
    Skalpe IO; Amundsen P
    Radiology; 1975 Jul; 116(1):101-6. PubMed ID: 1138257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local toxicity of metrizamide on intravascular injection. Effect on kidney, liver and blood-brain barrier.
    Salvesen S
    Acta Radiol Suppl; 1973; 335():166-74. PubMed ID: 4534550
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of radiographic contrast agents on spinal cord physiology.
    Bryan RN; Dauth GW; Gilman S; Hilal SK
    Invest Radiol; 1981; 16(3):234-9. PubMed ID: 7263159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Release of serotonin from human platelets in vitro by radiographic contrast media.
    Ring J; Sovak M
    Invest Radiol; 1981; 16(3):245-8. PubMed ID: 7053228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraventricular application of water-soluble contrast media in cats.
    Oftedal SI
    Acta Radiol Suppl; 1973; 335():125-32. PubMed ID: 4534546
    [No Abstract]   [Full Text] [Related]  

  • 53. Late meningeal effects of myelographic contrast media with special reference to metrizamide.
    Hansen EB; Fahrenkrug A; Praestholm J
    Br J Radiol; 1978 May; 51(605):321-7. PubMed ID: 638401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The postoperative myelogram. Radiographic evaluation of arachnoiditis and dural/arachnoidal tears.
    Quencer RM; Tenner M; Rothman L
    Radiology; 1977 Jun; 123(3):667-79. PubMed ID: 193147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular reactions to myelography with watersoluble contrast media.
    Praestholm J; Moller S
    Neuroradiology; 1977 Jun; 13(4):195-9. PubMed ID: 876452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amipaque myelography. The side effects compared with Dimer X.
    Ahlgren P
    Neuroradiology; 1975 Aug; 9(4):197-202. PubMed ID: 1186965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychopathometric demonstration and quantification of mental disturbances following myelography with metrizamide and iopamidol.
    Galle G; Huk W; Arnold K
    Neuroradiology; 1984; 26(3):229-33. PubMed ID: 6738855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventriculography with non-ionic water-soluble contrast medium, Amipaque (metrizamide). Comparative experimental and clinical studies.
    Suzuki S; Ito K; Iwabuchi T
    J Neurosurg; 1977 Jul; 47(1):79-85. PubMed ID: 301181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A clinical and experimental study of meglumine iocarmate in the subarachnoid space: a complication of positive contrast ventriculography.
    Yonekawa Y; Nishikawa M; Egli M; Klaiber R
    Surg Neurol; 1976 Mar; 5(3):167-70. PubMed ID: 816023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of pH of metrizamide on hypotension following intra-aortic injection. An investigation in rabbits of non-ionic and ionic contrast media.
    Almén T
    Acta Radiol Suppl; 1973; 335():203-8. PubMed ID: 4534554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.